Evidence map›Paper›PMID 41160616›Full record

ArticlePloS one2025

Association of perchlorate, nitrate, and thiocyanate with age-related macular degeneration in the United States.

Shiyu Jia, Qin Liu, Peng Liu, Wenli Zhao, Shanshan Li

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shiyu JiaDepartment of Ophthalmology, Workers' Hospital of Jinchuan Group Co., Ltd., Jinchang, Gansu, China.
Qin LiuGansu Aier Eye Hospital, Lanzhou, Gansu, China.
Peng LiuNeonatal Intensive Care Unit, Workers' Hospital of Jinchuan Group Co., Ltd., Jinchang, Gansu, China.
Wenli ZhaoDepartment of Ophthalmology, Workers' Hospital of Jinchuan Group Co., Ltd., Jinchang, Gansu, China.
Shanshan LiDepartment of Ophthalmology, Workers' Hospital of Jinchuan Group Co., Ltd., Jinchang, Gansu, China.ORCID https://orcid.org/0009-0006-8663-3029

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perchlorate, nitrate, and thiocyanate are endocrine-disrupting chemicals, but their associations with AMD is unclear. This study aims to investigate this relationship. We included 4727 participants aged 40 years and older from the National Health and Nutrition Examination Survey (NHANES) 2005-2008. Logistic regression analysis, restricted cubic spline (RCS), and weighted quantile sum (WQS) were applied to investigate the single, non-linear, and combined effects on AMD risk. Nitrate exposure was positively associated with any AMD risk (OR Any AMD, 1.19; 95% CI, 1.05-1.35; P = 0.010) and early AMD risk (OR Early AMD, 1.19; 95% CI, 1.05-1.36; P = 0.010); compared to the first quartile, the highest quartile of nitrate (OR, 1.94; 95% CI, 1.18-3.19; P = 0.012) and thiocyanate (OR, 1.70; 95% CI, 1.19-2.42; P = 0.006) levels were positively associated with AMD risk. The results of RCS showed a nonlinear relationship between nitrate exposure (P for nonlinearity = 0.020), thiocyanate (P for nonlinearity = 0.041), and AMD risk. WQS analysis indicated a positive relationship between mixed exposure and AMD risk (OR, 1.24; 95% CI, 1.01 to 1.51; P = 0.037). This study indicated that high urinary nitrate and thiocyanate levels were associated with an increased AMD risk among US adults. However, the cross-sectional design precludes causal inference.

Indexed as

Macular DegenerationNitratesPerchloratesThiocyanatesAdultAgedFemaleHumansMaleMiddle AgedNutrition SurveysRisk FactorsUnited StatesNitratesperchloratePerchloratesthiocyanateThiocyanates

Identifiers

PMID41160616
PMCPMC12571269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.